JBS N.V. (JBS) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, JBS trades at $12.89 with a market cap of $13.77B and a P/E ratio of 0.00. JBS moved +3.40% today. Year to date, JBS is -7.66%; over the trailing twelve months it is flat. Its 52-week range spans $12.37 to $18.65. Analyst consensus is strong buy with an average price target of $20.50. Rallies surfaces JBS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
JBS drops after JPMorgan downgrades shares on industry headwinds: A major broker downgrade hit JBS on 2026-05-14, citing industry headwinds and cycle pressures. The move follows a recent Q1 2026 earnings release showing a sharp year-over-year profit decline, keeping sentiment negative.
| Metric | Value |
|---|---|
| Price | $12.89 |
| Market Cap | $13.77B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 1.00% |
| 52-Week High | $18.65 |
| 52-Week Low | $12.37 |
| Volume | 485 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover JBS: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.50.